BioRestorative Therapies

BRTX · NASDAQ

$1.56−$0.04 (−2.50%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $1.60

Latest news

NewsSep 3, 4:43 AM ETAvi Kapoor
Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
NewsAug 14, 4:48 PM ET
Biorestorative Therapies Suspends All Orders, Shipments Of ExoCR, BioX Biocosmeceutical Product Lines Effective Immediately, On Aug 7; Conducting Review Of The Documentation, Sourcing, Regulatory Status Associated With Suspended Products; Has Not Made Decision To Discontinue Suspended Product Lines
NewsAug 7, 5:05 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
NewsJul 31, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsJun 4, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsMay 28, 8:06 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsMay 27, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsMay 27, 10:35 AM ETAvi Kapoor
Dow Jumps Over 300 Points; Dick's Sporting Shares Fall After Q1 Results
Press releaseMay 27, 7:45 AM ETPRNewswire
Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX)
NewsMay 19, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseApr 7, 8:15 AM ETGlobe Newswire
BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform
NewsMar 10, 8:06 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Press releaseMar 5, 8:00 AM ETGlobe Newswire
BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026
Press releaseMar 4, 8:00 AM ETGlobe Newswire
BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy
NewsFeb 25, 7:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsFeb 24, 12:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsFeb 20, 12:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsFeb 12, 12:34 PM ETAvi Kapoor
S&P 500 Falls Over 1%; American Electric Power Shares Gain After Upbeat Earnings
NewsFeb 12, 10:05 AM ETAvi Kapoor
Dow Jumps Over 200 Points; US Initial Jobless Claims Fall
NewsFeb 12, 7:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsFeb 10, 8:10 AM ET
BioRestorative Therapies Completes Patient Enrollment In Its Phase 2 Trial Of BRTX-100 For Chronic Lumbar Disc Disease
Press releaseFeb 10, 8:00 AM ETGlobe Newswire
BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease
NewsNov 20, 12:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsNov 19, 4:07 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsNov 11, 1:02 PM ET
Earnings Outlook For BioRestorative Therapies
Press releaseNov 5, 4:30 PM ETGlobe Newswire
BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025
Press releaseOct 7, 9:25 AM ETGlobe Newswire
BioRestorative CEO Lance Alstodt Interviewed on "The Big Biz Show"
Press releaseAug 12, 4:05 PM ETGlobe Newswire
BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
Press releaseAug 5, 4:30 PM ETGlobe Newswire
BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025
Press releaseJun 13, 7:45 AM ETGlobe Newswire
BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
Press releaseMay 14, 4:05 PM ETGlobe Newswire
BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update
Press releaseMay 8, 4:30 PM ETGlobe Newswire
BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
Press releaseApr 15, 8:30 AM ETGlobe Newswire
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities
Press releaseMar 27, 4:05 PM ETGlobe Newswire
BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update
NewsMar 26, 3:02 PM ET
Earnings Preview For BioRestorative Therapies
Press releaseFeb 10, 7:00 AM ETGlobe Newswire
BRTX-100 Front and Center at ORS 2025
NewsNov 13, 12:05 PM ETVandana Singh
BioRestorative Therapies Lower Back Candidate Shows Decrease In Pain, Increased Function
Press releaseNov 12, 4:05 PM ETGlobe Newswire
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
Press releaseNov 5, 7:10 AM ETGlobe Newswire
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
NewsOct 31, 4:34 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseSep 19, 6:55 AM ETGlobe Newswire
BioRestorative Therapies' IFATS 2024 Presentation to Feature ThermoStem® Platform's Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket

Biorestorative Therapies Suspends All Orders, Shipments Of ExoCR, BioX Biocosmeceutical Product Lines Effective Immediately, On Aug 7; Conducting Review Of The Documentation, Sourcing, Regulatory Status Associated With Suspended Products; Has Not Made Decision To Discontinue Suspended Product Lines

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Dow Jumps Over 300 Points; Dick's Sporting Shares Fall After Q1 Results

Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX)

12 Health Care Stocks Moving In Tuesday's After-Market Session

BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026

BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session

S&P 500 Falls Over 1%; American Electric Power Shares Gain After Upbeat Earnings

Dow Jumps Over 200 Points; US Initial Jobless Claims Fall

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BioRestorative Therapies Completes Patient Enrollment In Its Phase 2 Trial Of BRTX-100 For Chronic Lumbar Disc Disease

BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

Earnings Outlook For BioRestorative Therapies

BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025

BioRestorative CEO Lance Alstodt Interviewed on "The Big Biz Show"

BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update

BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update

BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities

BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update

Earnings Preview For BioRestorative Therapies

BRTX-100 Front and Center at ORS 2025

BioRestorative Therapies Lower Back Candidate Shows Decrease In Pain, Increased Function

BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update

BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health

12 Health Care Stocks Moving In Thursday's After-Market Session

BioRestorative Therapies' IFATS 2024 Presentation to Feature ThermoStem® Platform's Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs